Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease
about
Recent advances in quantitative neuroproteomicsHaptoglobin increases with age in rat hippocampus and modulates Apolipoprotein E mediated cholesterol trafficking in neuroblastoma cell lines.Neurovascular abnormalities in brain disorders: highlights with angiogenesis and magnetic resonance imaging studies.Prothrombin structure: unanticipated features and opportunities.Ubiquitin: a potential cerebrospinal fluid progression marker in Huntington's disease.Proteomic profiling of serum samples from chikungunya-infected patients provides insights into host responseBrain asymmetry: both sides of the story.Protein-protein interactions: switch from classical methods to proteomics and bioinformatics-based approaches.New insight into neurodegeneration: the role of proteomics.Challenges of Huntington's disease and quest for therapeutic biomarkers.Cerebrospinal Fluid Biomarkers for Huntington's Disease.Insights into the human brain proteome: Disclosing the biological meaning of protein networks in cerebrospinal fluid.Haptoglobin modulates beta-amyloid uptake by U-87 MG astrocyte cell line.The enzyme lecithin-cholesterol acyltransferase esterifies cerebrosterol and limits the toxic effect of this oxysterol on SH-SY5Y cells.Structural Architecture of Prothrombin in Solution Revealed by Single Molecule Spectroscopy.Aging Systemic Milieu Impairs Outcome after Ischemic Stroke in Rats.Aberrant astrocytes impair vascular reactivity in Huntington disease.Disulfide proteomics for identification of extracellular or secreted proteins.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.Mitochondrial Targeting in Neurodegeneration: A Heme Perspective
P2860
Q27000073-E7C37CF4-4DCA-4AD4-9DAD-0065744CFDCEQ29346953-E62F9052-FDCC-4F39-AAC2-6689C0B26BE4Q30653662-A8491BD2-44C8-4860-A9E2-17FBA7F21C51Q35033463-A248B85B-D06F-4700-A867-7F1E1D3D15A1Q35663352-763C1A99-8E73-46F8-910D-3DA154769F2EQ37428301-75ABDBE0-AB26-4C12-B01D-544035DC824EQ37956662-4C7CC3DA-1012-4869-95E9-F86DE1EC355DQ38098433-14DBE1D0-833A-4188-82C8-216A51F6B43CQ38170010-CC34692D-DAF8-40EC-9E00-3CEE42E0DD7BQ38257697-D3C38D45-6C38-4B01-857B-747B450364D3Q38794551-0674EDC8-5674-4B59-85F0-8939DA2A98B2Q38844925-05BCA72E-D4E6-4553-8785-19C978932ECDQ38939828-2068B4D8-9C6D-4B8B-8DBF-824DB3918935Q39016322-02D3B3FF-A405-41DC-AF9D-E3C0F0C3F70DQ40949440-00113BCE-4935-470E-B168-308ECB53E098Q42018312-A72A24FC-CD72-4B28-BF6A-23F4F38684ABQ45305568-45199CE3-948F-494C-B443-483238F0B04EQ45958718-9AFAE28B-AC0F-4FC0-83AF-D6FD286927F7Q52721984-AD1CD631-A09C-496A-8CFA-9B5EBA7EEC3FQ57155833-6CCA4114-7F18-4654-B99B-DE63B034EAF7
P2860
Increased prothrombin, apolipoprotein A-IV, and haptoglobin in the cerebrospinal fluid of patients with Huntington's disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased prothrombin, apolipo ...... ents with Huntington's disease
@ast
Increased prothrombin, apolipo ...... ents with Huntington's disease
@en
Increased prothrombin, apolipo ...... ents with Huntington's disease
@nl
type
label
Increased prothrombin, apolipo ...... ents with Huntington's disease
@ast
Increased prothrombin, apolipo ...... ents with Huntington's disease
@en
Increased prothrombin, apolipo ...... ents with Huntington's disease
@nl
prefLabel
Increased prothrombin, apolipo ...... ents with Huntington's disease
@ast
Increased prothrombin, apolipo ...... ents with Huntington's disease
@en
Increased prothrombin, apolipo ...... ents with Huntington's disease
@nl
P2093
P2860
P1433
P1476
Increased prothrombin, apolipo ...... ents with Huntington's disease
@en
P2093
Chiung-Mei Chen
Mu-Yun Tseng
Sen-Yung Hsieh
Yen-Chu Huang
Yi-Chun Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0015809
P407
P577
2011-01-31T00:00:00Z